News
CAMBRIDGE, MA / ACCESSWIRE / April 27, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Arpa Garay will ...
On May 31, Arpa Garay will enter the Moderna fold as chief commercial officer, the company said Wednesday. As a member of the biotech’s executive committee, Garay will report to Moderna helmsman ...
(Reuters) -Moderna said its Chief Commercial Officer Arpa Garay has stepped down from the role and CEO Stephane Bancel will look over sales and marketing, sending the shares of the vaccine maker ...
Pharma marketing maven Arpa Garay is swapping the pharma C-suite for the biotech one. Moderna has wooed the 16-year Merck vet to join as chief commercial officer, the company said Wednesday. As part ...
Arpa Garay's most active month to dispose stocks was the month of April. 2022 saw Arpa Garay paying a total of $291,312.14 for 24,678 shares, this is the most they've acquired in one year.
Arpa Garay will lead Human Health Global Marketing, Jannie Oosthuizen will lead Human Health U.S., and Merck is recruiting externally to fill the Human Health International role.
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced that Arpa Garay will join Moderna as Chief Commercial Officer, effective Monday, May 31 ...
Ms. Garay joins Moderna from Merck & Co., Inc. (MRK) where she most recently served as Chief Marketing Officer for Merck's Human Health business; she reported to Merck's Chief Executive Officer ...
Ms. Garay joins Moderna from Merck & Co., Inc. (MRK) where she most recently served as Chief Marketing Officer for Merck's Human Health business; she reported to Merck's Chief Executive Officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results